Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 18 Carcinoma, Non-Small-Cell Lung 6 Glioma 5 Brain Neoplasms 5 Head and Neck Neoplasms 4 Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Esophageal Neoplasms 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Astrocytoma 3 Stomach Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Pain 2 Lung Neoplasms 2 Gliosarcoma 2 Central Nervous System Neoplasms 2 Bone Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomatitis 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1

Interventions

Imatinib Mesylate 2 Cetuximab 2 spartalizumab 1 pembrolizumab 1 avelumab 1 Radiotherapy 1 Radiation 1 Cyclophosphamide 1 Bacterial Load 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Chordoma × Radiation × Clear all

NCT03595228 2023-04-14

BN Brachyury and Radiation in Chordoma

Bavarian Nordic

Phase 2 Completed

29 enrolled 20 charts

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡